On Tuesday shares of VeriSign, Inc. (NASDAQ:VRSN) closed at $66.29. Company’s sales growth for last 5 years was 10.40% and EPS growth for next 5 years is recorded as 12.00%. VeriSign, Inc. (NASDAQ: VRSN) on 12 March 2015, announced that 4 million domain names were added to the Internet in the fourth quarter of 2014, bringing the total number of registered domain names to 288 million worldwide across all top-level domains (TLDs) as of Dec. 31, 2014 in the domain industry report.
Nuverra Environmental Solutions, Inc. (NYSE:NES) in last trading activity moved down -1.06% to close at $3.74. Company weekly performance is 8.72% while its quarterly performance stands at -41.84%. Nuverra Environmental Solutions, Inc. (NYSE:NES) is -82.43% away from its 52 week high. Nuverra Environmental Solutions, Inc. (NYSE: NES) announced financial results on 16 March 2015, for the fourth quarter and full fiscal year ended December 31, 2014. Revenue from continuing operations increased 10.4% over the prior year to $141.8 million for the quarter and was up 2% to $536.3 million for the year.
On last trading day Enterprise Financial Services Corp. (NASDAQ:EFSC) moved down -0.29% to close at $20.79. Its volatility for the week is 1.48% while volatility for the month is 1.52%. EFSC’s sales growth for past 5 years was 2.20% and its EPS growth for past 5 years was 18.70%. Enterprise Financial Services Corp. (NASDAQ:EFSC) monthly performance is 3.85%. Enterprise Financial Services Corp. (NASDAQ:EFSC) on 18 March 2015, released its 2014 proxy statement and in it revealed that president and CEO Peter Benoist’s pay declined 13 percent from 2013, to $1.22 million. The change was largely due to a decrease in stock awards. Benoist’s pay rose 36 percent from 2012 to 2013.
The Medicines Company (NASDAQ:MDCO) has 0.80% insider ownership while its institutional ownership stands at 86.50%. In last trading activity company’s stock closed at $30.16. The Medicines Company (NASDAQ:MDCO) announced that new data from several clinical trials, including the late-breaking MATRIX trial of ANGIOX® (bivalirudin), from across its cardiovascular product and pipeline portfolio presented at the 64th Annual Scientific Session of the American College of Cardiology, held March 14-16, in San Diego.
On last trading day Bryn Mawr Bank Corp. (NASDAQ:BMTC) advanced 0.66% to close at $30.44. Its volatility for the week is 1.71% while volatility for the month is 1.53%. BMTC’s sales growth for past 5 years was 7.80% and its EPS growth for past 5 years was 11.20%. Bryn Mawr Bank Corp. (NASDAQ:BMTC) monthly performance is 3.57%. Analysts at Zacks upgraded shares of Bryn Mawr Bank Corp. (NASDAQ:BMTC) from a “neutral” rating to an “outperform” rating.